Efforts in the research lab of Jörg Gerlach, MD, focus on liver stem cell transplant for people with end-stage liver disease.
Liver cell transplant holds the promise of bridging people with liver failure to whole liver transplant. But suitable cell populations are under debate.
Other cell sources we’re studying include mesenchymal stem cells and hematopoietic stem cells.
McGowan Institute for Regenerative Medicine
450 Technology Drive
Pittsburgh, PA 15219